nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—CCND1—brain cancer	0.483	1	CbGaD
Arsenic trioxide—CYP1B1—Procarbazine—brain cancer	0.209	0.674	CbGbCtD
Arsenic trioxide—ABCC2—Carboplatin—brain cancer	0.0268	0.0868	CbGbCtD
Arsenic trioxide—ABCC2—Etoposide—brain cancer	0.0225	0.0729	CbGbCtD
Arsenic trioxide—CYP3A4—Temozolomide—brain cancer	0.0214	0.0693	CbGbCtD
Arsenic trioxide—CYP3A4—Lomustine—brain cancer	0.0182	0.0589	CbGbCtD
Arsenic trioxide—ABCB1—Etoposide—brain cancer	0.00735	0.0238	CbGbCtD
Arsenic trioxide—CYP3A4—Etoposide—brain cancer	0.0044	0.0142	CbGbCtD
Arsenic trioxide—CCND1—blood vessel—brain cancer	0.00211	0.0331	CbGeAlD
Arsenic trioxide—AKT1—ganglion—brain cancer	0.00186	0.0293	CbGeAlD
Arsenic trioxide—TXNRD1—Teniposide—Etoposide—brain cancer	0.0018	1	CbGdCrCtD
Arsenic trioxide—MAPK3—endothelium—brain cancer	0.0017	0.0268	CbGeAlD
Arsenic trioxide—MAPK1—hindbrain—brain cancer	0.00169	0.0266	CbGeAlD
Arsenic trioxide—JUN—ganglion—brain cancer	0.00162	0.0255	CbGeAlD
Arsenic trioxide—AKT1—endothelium—brain cancer	0.00161	0.0252	CbGeAlD
Arsenic trioxide—MAPK3—blood vessel—brain cancer	0.00157	0.0247	CbGeAlD
Arsenic trioxide—AKT1—blood vessel—brain cancer	0.00148	0.0233	CbGeAlD
Arsenic trioxide—AKT1—hindbrain—brain cancer	0.00141	0.0222	CbGeAlD
Arsenic trioxide—JUN—endothelium—brain cancer	0.0014	0.022	CbGeAlD
Arsenic trioxide—JUN—blood vessel—brain cancer	0.00129	0.0203	CbGeAlD
Arsenic trioxide—JUN—hindbrain—brain cancer	0.00123	0.0193	CbGeAlD
Arsenic trioxide—CCND1—telencephalon—brain cancer	0.00102	0.0161	CbGeAlD
Arsenic trioxide—MAPK1—brainstem—brain cancer	0.000971	0.0152	CbGeAlD
Arsenic trioxide—MAPK1—telencephalon—brain cancer	0.000862	0.0135	CbGeAlD
Arsenic trioxide—CCND1—gonad—brain cancer	0.000853	0.0134	CbGeAlD
Arsenic trioxide—CCND1—pituitary gland—brain cancer	0.000832	0.0131	CbGeAlD
Arsenic trioxide—AKT1—brainstem—brain cancer	0.00081	0.0127	CbGeAlD
Arsenic trioxide—CCND1—medulla oblongata—brain cancer	0.000803	0.0126	CbGeAlD
Arsenic trioxide—TXNRD1—telencephalon—brain cancer	0.000802	0.0126	CbGeAlD
Arsenic trioxide—MAPK3—telencephalon—brain cancer	0.000762	0.012	CbGeAlD
Arsenic trioxide—CCND1—midbrain—brain cancer	0.000734	0.0115	CbGeAlD
Arsenic trioxide—AKT1—telencephalon—brain cancer	0.000719	0.0113	CbGeAlD
Arsenic trioxide—MAPK1—gonad—brain cancer	0.000719	0.0113	CbGeAlD
Arsenic trioxide—CCND1—spinal cord—brain cancer	0.000716	0.0112	CbGeAlD
Arsenic trioxide—JUN—brainstem—brain cancer	0.000705	0.0111	CbGeAlD
Arsenic trioxide—TXNRD1—gonad—brain cancer	0.000669	0.0105	CbGeAlD
Arsenic trioxide—TXNRD1—pituitary gland—brain cancer	0.000653	0.0103	CbGeAlD
Arsenic trioxide—CCND1—endocrine gland—brain cancer	0.000645	0.0101	CbGeAlD
Arsenic trioxide—CCND1—head—brain cancer	0.000637	0.01	CbGeAlD
Arsenic trioxide—MAPK3—gonad—brain cancer	0.000636	0.00999	CbGeAlD
Arsenic trioxide—TXNRD1—medulla oblongata—brain cancer	0.00063	0.00989	CbGeAlD
Arsenic trioxide—JUN—telencephalon—brain cancer	0.000626	0.00983	CbGeAlD
Arsenic trioxide—IKBKB—telencephalon—brain cancer	0.000623	0.00978	CbGeAlD
Arsenic trioxide—MAPK3—pituitary gland—brain cancer	0.000621	0.00975	CbGeAlD
Arsenic trioxide—MAPK1—spinal cord—brain cancer	0.000604	0.00948	CbGeAlD
Arsenic trioxide—AKT1—gonad—brain cancer	0.0006	0.00942	CbGeAlD
Arsenic trioxide—MAPK3—medulla oblongata—brain cancer	0.000599	0.00941	CbGeAlD
Arsenic trioxide—AKT1—pituitary gland—brain cancer	0.000585	0.00919	CbGeAlD
Arsenic trioxide—CCND1—central nervous system—brain cancer	0.000581	0.00912	CbGeAlD
Arsenic trioxide—TXNRD1—midbrain—brain cancer	0.000576	0.00904	CbGeAlD
Arsenic trioxide—CCND1—cerebellum—brain cancer	0.000568	0.00892	CbGeAlD
Arsenic trioxide—AKT1—medulla oblongata—brain cancer	0.000565	0.00887	CbGeAlD
Arsenic trioxide—TXNRD1—spinal cord—brain cancer	0.000562	0.00882	CbGeAlD
Arsenic trioxide—MAPK3—midbrain—brain cancer	0.000548	0.0086	CbGeAlD
Arsenic trioxide—MAPK1—endocrine gland—brain cancer	0.000543	0.00853	CbGeAlD
Arsenic trioxide—MAPK1—head—brain cancer	0.000536	0.00842	CbGeAlD
Arsenic trioxide—MAPK3—spinal cord—brain cancer	0.000534	0.00839	CbGeAlD
Arsenic trioxide—JUN—gonad—brain cancer	0.000522	0.0082	CbGeAlD
Arsenic trioxide—IKBKB—gonad—brain cancer	0.00052	0.00816	CbGeAlD
Arsenic trioxide—AKT1—midbrain—brain cancer	0.000516	0.00811	CbGeAlD
Arsenic trioxide—JUN—pituitary gland—brain cancer	0.00051	0.008	CbGeAlD
Arsenic trioxide—IKBKB—pituitary gland—brain cancer	0.000507	0.00796	CbGeAlD
Arsenic trioxide—TXNRD1—endocrine gland—brain cancer	0.000506	0.00794	CbGeAlD
Arsenic trioxide—AKT1—spinal cord—brain cancer	0.000504	0.00791	CbGeAlD
Arsenic trioxide—TXNRD1—head—brain cancer	0.000499	0.00784	CbGeAlD
Arsenic trioxide—JUN—medulla oblongata—brain cancer	0.000492	0.00772	CbGeAlD
Arsenic trioxide—MAPK1—central nervous system—brain cancer	0.00049	0.00769	CbGeAlD
Arsenic trioxide—MAPK3—endocrine gland—brain cancer	0.000481	0.00755	CbGeAlD
Arsenic trioxide—MAPK1—cerebellum—brain cancer	0.000479	0.00752	CbGeAlD
Arsenic trioxide—MAPK3—head—brain cancer	0.000475	0.00745	CbGeAlD
Arsenic trioxide—CCND1—brain—brain cancer	0.000461	0.00724	CbGeAlD
Arsenic trioxide—TXNRD1—central nervous system—brain cancer	0.000456	0.00716	CbGeAlD
Arsenic trioxide—AKT1—endocrine gland—brain cancer	0.000454	0.00712	CbGeAlD
Arsenic trioxide—JUN—midbrain—brain cancer	0.000449	0.00706	CbGeAlD
Arsenic trioxide—AKT1—head—brain cancer	0.000448	0.00703	CbGeAlD
Arsenic trioxide—TXNRD1—cerebellum—brain cancer	0.000445	0.00699	CbGeAlD
Arsenic trioxide—JUN—spinal cord—brain cancer	0.000439	0.00689	CbGeAlD
Arsenic trioxide—MAPK3—central nervous system—brain cancer	0.000433	0.0068	CbGeAlD
Arsenic trioxide—MAPK3—cerebellum—brain cancer	0.000424	0.00665	CbGeAlD
Arsenic trioxide—AKT1—central nervous system—brain cancer	0.000409	0.00642	CbGeAlD
Arsenic trioxide—AKT1—cerebellum—brain cancer	0.000399	0.00627	CbGeAlD
Arsenic trioxide—JUN—endocrine gland—brain cancer	0.000395	0.0062	CbGeAlD
Arsenic trioxide—IKBKB—endocrine gland—brain cancer	0.000393	0.00617	CbGeAlD
Arsenic trioxide—JUN—head—brain cancer	0.00039	0.00612	CbGeAlD
Arsenic trioxide—MAPK1—brain—brain cancer	0.000389	0.0061	CbGeAlD
Arsenic trioxide—IKBKB—head—brain cancer	0.000388	0.00609	CbGeAlD
Arsenic trioxide—TXNRD1—brain—brain cancer	0.000362	0.00568	CbGeAlD
Arsenic trioxide—JUN—central nervous system—brain cancer	0.000356	0.00559	CbGeAlD
Arsenic trioxide—IKBKB—central nervous system—brain cancer	0.000354	0.00556	CbGeAlD
Arsenic trioxide—JUN—cerebellum—brain cancer	0.000348	0.00546	CbGeAlD
Arsenic trioxide—IKBKB—cerebellum—brain cancer	0.000346	0.00543	CbGeAlD
Arsenic trioxide—MAPK3—brain—brain cancer	0.000344	0.0054	CbGeAlD
Arsenic trioxide—CYP1B1—telencephalon—brain cancer	0.000334	0.00524	CbGeAlD
Arsenic trioxide—AKT1—brain—brain cancer	0.000324	0.00509	CbGeAlD
Arsenic trioxide—JUN—brain—brain cancer	0.000282	0.00443	CbGeAlD
Arsenic trioxide—IKBKB—brain—brain cancer	0.000281	0.00441	CbGeAlD
Arsenic trioxide—CYP1B1—gonad—brain cancer	0.000278	0.00437	CbGeAlD
Arsenic trioxide—CYP1B1—pituitary gland—brain cancer	0.000272	0.00427	CbGeAlD
Arsenic trioxide—ABCB1—blood vessel—brain cancer	0.000253	0.00397	CbGeAlD
Arsenic trioxide—ABCC2—endocrine gland—brain cancer	0.000215	0.00337	CbGeAlD
Arsenic trioxide—CYP1B1—endocrine gland—brain cancer	0.00021	0.0033	CbGeAlD
Arsenic trioxide—CYP1B1—head—brain cancer	0.000208	0.00326	CbGeAlD
Arsenic trioxide—CYP1B1—central nervous system—brain cancer	0.00019	0.00298	CbGeAlD
Arsenic trioxide—CYP1B1—cerebellum—brain cancer	0.000185	0.00291	CbGeAlD
Arsenic trioxide—CYP1B1—brain—brain cancer	0.000151	0.00236	CbGeAlD
Arsenic trioxide—CYP1A1—endocrine gland—brain cancer	0.000149	0.00234	CbGeAlD
Arsenic trioxide—CYP1A1—head—brain cancer	0.000147	0.00231	CbGeAlD
Arsenic trioxide—CYP1A1—central nervous system—brain cancer	0.000134	0.0021	CbGeAlD
Arsenic trioxide—ABCB1—telencephalon—brain cancer	0.000123	0.00192	CbGeAlD
Arsenic trioxide—CYP3A4—endocrine gland—brain cancer	0.000109	0.00171	CbGeAlD
Arsenic trioxide—CYP1A1—brain—brain cancer	0.000106	0.00167	CbGeAlD
Arsenic trioxide—ABCB1—gonad—brain cancer	0.000102	0.00161	CbGeAlD
Arsenic trioxide—ABCB1—pituitary gland—brain cancer	9.98e-05	0.00157	CbGeAlD
Arsenic trioxide—CYP3A4—central nervous system—brain cancer	9.84e-05	0.00154	CbGeAlD
Arsenic trioxide—ABCB1—medulla oblongata—brain cancer	9.63e-05	0.00151	CbGeAlD
Arsenic trioxide—ABCB1—midbrain—brain cancer	8.8e-05	0.00138	CbGeAlD
Arsenic trioxide—ABCB1—spinal cord—brain cancer	8.58e-05	0.00135	CbGeAlD
Arsenic trioxide—ABCB1—endocrine gland—brain cancer	7.73e-05	0.00121	CbGeAlD
Arsenic trioxide—ABCB1—head—brain cancer	7.63e-05	0.0012	CbGeAlD
Arsenic trioxide—ABCB1—central nervous system—brain cancer	6.96e-05	0.00109	CbGeAlD
Arsenic trioxide—ABCB1—cerebellum—brain cancer	6.81e-05	0.00107	CbGeAlD
Arsenic trioxide—ABCB1—brain—brain cancer	5.53e-05	0.000868	CbGeAlD
Arsenic trioxide—CYP1A1—Metabolism—BSG—brain cancer	7.03e-06	4.93e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TRPC6—brain cancer	6.95e-06	4.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—PDGFRA—brain cancer	6.93e-06	4.86e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—HES1—brain cancer	6.93e-06	4.86e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SHH—brain cancer	6.9e-06	4.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—IL2—brain cancer	6.86e-06	4.81e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—RELA—brain cancer	6.86e-06	4.81e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PTCH1—brain cancer	6.83e-06	4.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SMO—brain cancer	6.83e-06	4.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—ERBB2—brain cancer	6.82e-06	4.78e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—CTNNB1—brain cancer	6.75e-06	4.74e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—CTNNB1—brain cancer	6.73e-06	4.72e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—HES1—brain cancer	6.72e-06	4.72e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—PIK3CG—brain cancer	6.68e-06	4.69e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TRPC6—brain cancer	6.65e-06	4.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—CCND1—brain cancer	6.64e-06	4.66e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP2C9—brain cancer	6.61e-06	4.64e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—PDGFRA—brain cancer	6.6e-06	4.63e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—PDGFRA—brain cancer	6.59e-06	4.63e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—RELA—brain cancer	6.56e-06	4.6e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PTCH1—brain cancer	6.54e-06	4.59e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SMO—brain cancer	6.54e-06	4.59e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IRS2—brain cancer	6.53e-06	4.58e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—ERBB2—brain cancer	6.52e-06	4.58e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CTNNB1—brain cancer	6.46e-06	4.53e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	6.46e-06	4.53e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—VEGFA—brain cancer	6.44e-06	4.52e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—PDGFRA—brain cancer	6.4e-06	4.49e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	6.4e-06	4.49e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—HES1—brain cancer	6.39e-06	4.49e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—STAT3—brain cancer	6.38e-06	4.48e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—VEGFA—brain cancer	6.32e-06	4.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—CCND1—brain cancer	6.31e-06	4.43e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—PDGFRA—brain cancer	6.31e-06	4.43e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—RELA—brain cancer	6.3e-06	4.42e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IRS2—brain cancer	6.27e-06	4.4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CTNNB1—brain cancer	6.27e-06	4.4e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—ERBB2—brain cancer	6.26e-06	4.39e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—VEGFA—brain cancer	6.25e-06	4.38e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—STAT3—brain cancer	6.19e-06	4.34e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NOTCH2—brain cancer	6.16e-06	4.32e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—VEGFA—brain cancer	6.13e-06	4.3e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—RELA—brain cancer	6.1e-06	4.28e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—PDGFRA—brain cancer	6.09e-06	4.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IRS2—brain cancer	6.09e-06	4.27e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—PIK3CG—brain cancer	6.06e-06	4.25e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—ERBB2—brain cancer	6.06e-06	4.25e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—IDH1—brain cancer	6.05e-06	4.24e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CTNNB1—brain cancer	5.96e-06	4.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle, Mitotic—MYC—brain cancer	5.95e-06	4.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—VEGFA—brain cancer	5.95e-06	4.17e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NOTCH2—brain cancer	5.92e-06	4.15e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—STAT3—brain cancer	5.89e-06	4.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—PIK3CG—brain cancer	5.88e-06	4.13e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—VAV1—brain cancer	5.87e-06	4.12e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—VEGFA—brain cancer	5.83e-06	4.09e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—EGFR—brain cancer	5.8e-06	4.07e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—IRS2—brain cancer	5.79e-06	4.06e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IRS2—brain cancer	5.79e-06	4.06e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NOTCH2—brain cancer	5.74e-06	4.03e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CTNNB1—brain cancer	5.71e-06	4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle, Mitotic—MYC—brain cancer	5.66e-06	3.97e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—VAV1—brain cancer	5.64e-06	3.96e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	5.63e-06	3.95e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—EGFR—brain cancer	5.62e-06	3.95e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—IRS2—brain cancer	5.62e-06	3.94e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—BSG—brain cancer	5.62e-06	3.94e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—PIK3CG—brain cancer	5.6e-06	3.93e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IRS2—brain cancer	5.54e-06	3.89e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL2—brain cancer	5.49e-06	3.85e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—VAV1—brain cancer	5.47e-06	3.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NOTCH2—brain cancer	5.46e-06	3.83e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—EGFR—brain cancer	5.35e-06	3.75e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—IRS2—brain cancer	5.35e-06	3.75e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—EGFR—brain cancer	5.33e-06	3.74e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—MYC—brain cancer	5.32e-06	3.73e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—CTNNB1—brain cancer	5.3e-06	3.72e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NOTCH2—brain cancer	5.23e-06	3.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—VAV1—brain cancer	5.21e-06	3.65e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	5.18e-06	3.64e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—EGFR—brain cancer	5.12e-06	3.59e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—APC—brain cancer	5.12e-06	3.59e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	5.07e-06	3.56e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—MYC—brain cancer	5.06e-06	3.55e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HES1—brain cancer	5.05e-06	3.54e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—VAV1—brain cancer	4.98e-06	3.5e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—EGFR—brain cancer	4.97e-06	3.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—APC—brain cancer	4.96e-06	3.48e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.92e-06	3.46e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—EGFR—brain cancer	4.92e-06	3.45e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HES1—brain cancer	4.85e-06	3.4e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—IDH1—brain cancer	4.83e-06	3.39e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PDGFRA—brain cancer	4.81e-06	3.37e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ENO2—brain cancer	4.78e-06	3.35e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—TP53—brain cancer	4.78e-06	3.35e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—EGFR—brain cancer	4.73e-06	3.32e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—APC—brain cancer	4.72e-06	3.31e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HES1—brain cancer	4.71e-06	3.3e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—IL2—brain cancer	4.7e-06	3.3e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—SPP1—brain cancer	4.67e-06	3.28e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—VEGFA—brain cancer	4.67e-06	3.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—TP53—brain cancer	4.63e-06	3.25e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—STAT3—brain cancer	4.62e-06	3.24e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PDGFRA—brain cancer	4.62e-06	3.24e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—EGFR—brain cancer	4.52e-06	3.17e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—RELA—brain cancer	4.51e-06	3.16e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—SPP1—brain cancer	4.49e-06	3.15e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PDGFRA—brain cancer	4.48e-06	3.14e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HES1—brain cancer	4.48e-06	3.14e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—ERBB2—brain cancer	4.48e-06	3.14e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—TP53—brain cancer	4.41e-06	3.09e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—TP53—brain cancer	4.37e-06	3.07e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—SPP1—brain cancer	4.35e-06	3.05e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—EGFR—brain cancer	4.34e-06	3.05e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—RELA—brain cancer	4.33e-06	3.04e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—ERBB2—brain cancer	4.3e-06	3.02e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—MYC—brain cancer	4.29e-06	3.01e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HES1—brain cancer	4.28e-06	3.01e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—PIK3CG—brain cancer	4.28e-06	3.01e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL2—brain cancer	4.27e-06	2.99e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PDGFRA—brain cancer	4.26e-06	2.99e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.26e-06	2.99e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IRS2—brain cancer	4.22e-06	2.96e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—RELA—brain cancer	4.2e-06	2.95e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—EGFR—brain cancer	4.2e-06	2.95e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—ERBB2—brain cancer	4.17e-06	2.93e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—TP53—brain cancer	4.16e-06	2.92e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SPP1—brain cancer	4.14e-06	2.9e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL2—brain cancer	4.14e-06	2.9e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PDGFRA—brain cancer	4.08e-06	2.86e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP2C9—brain cancer	4.07e-06	2.86e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL2—brain cancer	4.06e-06	2.85e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IRS2—brain cancer	4.06e-06	2.85e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—RELA—brain cancer	4e-06	2.8e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—ERBB2—brain cancer	3.97e-06	2.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—ERBB2—brain cancer	3.97e-06	2.79e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SPP1—brain cancer	3.96e-06	2.78e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL2—brain cancer	3.94e-06	2.76e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IRS2—brain cancer	3.93e-06	2.76e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CTNNB1—brain cancer	3.92e-06	2.75e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL2—brain cancer	3.9e-06	2.74e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—ERBB2—brain cancer	3.85e-06	2.7e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—RELA—brain cancer	3.82e-06	2.68e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ENO2—brain cancer	3.82e-06	2.68e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—ERBB2—brain cancer	3.8e-06	2.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL2—brain cancer	3.78e-06	2.65e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CTNNB1—brain cancer	3.76e-06	2.64e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IRS2—brain cancer	3.74e-06	2.63e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—APC—brain cancer	3.73e-06	2.62e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PIK3CG—brain cancer	3.73e-06	2.62e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—ERBB2—brain cancer	3.67e-06	2.57e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CTNNB1—brain cancer	3.65e-06	2.56e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL2—brain cancer	3.6e-06	2.52e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PIK3CG—brain cancer	3.58e-06	2.51e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—APC—brain cancer	3.58e-06	2.51e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IRS2—brain cancer	3.58e-06	2.51e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PIK3CG—brain cancer	3.56e-06	2.5e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TP53—brain cancer	3.53e-06	2.47e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CTNNB1—brain cancer	3.48e-06	2.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—APC—brain cancer	3.47e-06	2.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PIK3CG—brain cancer	3.47e-06	2.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CTNNB1—brain cancer	3.47e-06	2.44e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—BSG—brain cancer	3.46e-06	2.43e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL2—brain cancer	3.44e-06	2.42e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—STAT3—brain cancer	3.42e-06	2.4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CTNNB1—brain cancer	3.37e-06	2.36e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CTNNB1—brain cancer	3.32e-06	2.33e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—APC—brain cancer	3.31e-06	2.32e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PIK3CG—brain cancer	3.31e-06	2.32e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—STAT3—brain cancer	3.28e-06	2.3e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—EGFR—brain cancer	3.26e-06	2.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CTNNB1—brain cancer	3.21e-06	2.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—STAT3—brain cancer	3.18e-06	2.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—EGFR—brain cancer	3.17e-06	2.22e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—APC—brain cancer	3.16e-06	2.22e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PIK3CG—brain cancer	3.16e-06	2.22e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—EGFR—brain cancer	3.1e-06	2.18e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—MYC—brain cancer	3.03e-06	2.13e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—STAT3—brain cancer	3.03e-06	2.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—STAT3—brain cancer	3.03e-06	2.12e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—EGFR—brain cancer	3.01e-06	2.11e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—EGFR—brain cancer	2.98e-06	2.09e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—IDH1—brain cancer	2.98e-06	2.09e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—MYC—brain cancer	2.94e-06	2.06e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—STAT3—brain cancer	2.94e-06	2.06e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—RELA—brain cancer	2.91e-06	2.04e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—STAT3—brain cancer	2.9e-06	2.03e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ERBB2—brain cancer	2.9e-06	2.03e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—EGFR—brain cancer	2.89e-06	2.03e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—MYC—brain cancer	2.81e-06	1.97e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—RELA—brain cancer	2.8e-06	1.96e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—STAT3—brain cancer	2.8e-06	1.96e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ERBB2—brain cancer	2.78e-06	1.95e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—EGFR—brain cancer	2.75e-06	1.93e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—EGFR—brain cancer	2.75e-06	1.93e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—MYC—brain cancer	2.73e-06	1.92e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—RELA—brain cancer	2.71e-06	1.9e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ERBB2—brain cancer	2.7e-06	1.89e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—EGFR—brain cancer	2.67e-06	1.87e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—EGFR—brain cancer	2.63e-06	1.85e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL2—brain cancer	2.62e-06	1.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—MYC—brain cancer	2.6e-06	1.82e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—RELA—brain cancer	2.58e-06	1.81e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ERBB2—brain cancer	2.57e-06	1.8e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCND1—brain cancer	2.56e-06	1.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—EGFR—brain cancer	2.54e-06	1.78e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CTNNB1—brain cancer	2.53e-06	1.78e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL2—brain cancer	2.52e-06	1.77e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—RELA—brain cancer	2.47e-06	1.73e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCND1—brain cancer	2.46e-06	1.72e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ERBB2—brain cancer	2.46e-06	1.72e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL2—brain cancer	2.45e-06	1.72e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CTNNB1—brain cancer	2.43e-06	1.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCND1—brain cancer	2.38e-06	1.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CTNNB1—brain cancer	2.36e-06	1.66e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ENO2—brain cancer	2.35e-06	1.65e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL2—brain cancer	2.33e-06	1.63e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCND1—brain cancer	2.27e-06	1.59e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CTNNB1—brain cancer	2.25e-06	1.58e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—VEGFA—brain cancer	2.23e-06	1.56e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL2—brain cancer	2.23e-06	1.56e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—STAT3—brain cancer	2.21e-06	1.55e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PIK3CG—brain cancer	2.19e-06	1.54e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCND1—brain cancer	2.17e-06	1.52e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CTNNB1—brain cancer	2.15e-06	1.51e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—VEGFA—brain cancer	2.14e-06	1.5e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—STAT3—brain cancer	2.12e-06	1.49e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—VEGFA—brain cancer	2.08e-06	1.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—STAT3—brain cancer	2.06e-06	1.44e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MYC—brain cancer	2.05e-06	1.44e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EGFR—brain cancer	2.01e-06	1.41e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—VEGFA—brain cancer	1.98e-06	1.39e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MYC—brain cancer	1.97e-06	1.38e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—STAT3—brain cancer	1.96e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EGFR—brain cancer	1.93e-06	1.35e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MYC—brain cancer	1.91e-06	1.34e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—VEGFA—brain cancer	1.89e-06	1.33e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—STAT3—brain cancer	1.87e-06	1.31e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EGFR—brain cancer	1.87e-06	1.31e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MYC—brain cancer	1.82e-06	1.28e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EGFR—brain cancer	1.78e-06	1.25e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PIK3CG—brain cancer	1.75e-06	1.23e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MYC—brain cancer	1.74e-06	1.22e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EGFR—brain cancer	1.7e-06	1.19e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TP53—brain cancer	1.68e-06	1.18e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TP53—brain cancer	1.62e-06	1.14e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TP53—brain cancer	1.57e-06	1.1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TP53—brain cancer	1.49e-06	1.05e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TP53—brain cancer	1.43e-06	1e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PIK3CG—brain cancer	1.08e-06	7.57e-06	CbGpPWpGaD
